Evidence map›Paper›PMID 28832877›Full record

ArticleJAMA psychiatry2017

Association of Lithium in Drinking Water With the Incidence of Dementia.

Lars Vedel Kessing, Thomas Alexander Gerds, Nikoline Nygård Knudsen, Lisbeth Flindt Jørgensen, Søren Munch Kristiansen, Denitza Voutchkova, Vibeke Ernstsen, Jörg Schullehner, Birgitte Hansen, Per Kragh Andersen and 1 more

Abstract read
In one paragraph

Article in JAMA psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 201 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  9. Review
  10. Review
  11. Premature aging in serious mental illness.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  12. Article
  13. Review
  14. A qualitative exploration of perspectives on taking lithium supplements.Therapeutic advances in psychopharmacology · 2026
    Article
  15. Review
  16. Lithium: Old Drug, New tricks?Current psychiatry reports · 2025
    Review
  17. Article
  18. Article
  19. Social determinants of dementia: A scoping review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Lars Vedel KessingPsychiatric Center Copenhagen, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Thomas Alexander GerdsDepartment of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
Nikoline Nygård KnudsenNational Institute of Public Health, University of Southern Denmark, Odense.
Lisbeth Flindt JørgensenGeological Survey of Denmark and Greenland, Copenhagen, Denmark.
Søren Munch KristiansenDepartment of Geoscience, Aarhus University, Aarhus, Denmark.
Denitza VoutchkovaGeological Survey of Denmark and Greenland, Copenhagen, Denmark.
Vibeke ErnstsenGeological Survey of Denmark and Greenland, Copenhagen, Denmark.
Jörg SchullehnerGeological Survey of Denmark and Greenland, Copenhagen, Denmark.
Birgitte HansenGeological Survey of Denmark and Greenland, Copenhagen, Denmark.
Per Kragh AndersenDepartment of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
Annette Kjær ErsbøllNational Institute of Public Health, University of Southern Denmark, Odense.
Geological Survey of Denmark and Greenland · DKUniversity of Copenhagen · DKUniversity of Southern Denmark · DKAarhus University · DKNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Results from animal and human studies suggest that lithium in therapeutic doses may improve learning and memory and modify the risk of developing dementia. Additional preliminary studies suggest that subtherapeutic levels, including microlevels of lithium, may influence human cognition. Objective: To investigate whether the incidence of dementia in the general population covaries with long-term exposure to microlevels of lithium in drinking water. Design, Setting, and Participants: This Danish nationwide, population-based, nested case-control study examined longitudinal, individual geographic data on municipality of residence and data from drinking water measurements combined with time-specific data from all patients aged 50 to 90 years with a hospital contact with a diagnosis of dementia from January 1, 1970, through December 31, 2013, and 10 age- and sex-matched control individuals from the Danish population. The mean lithium exposure in drinking water since 1986 was estimated for all study individuals. Data analysis was performed from January 1, 1995, through December 31, 2013. Main Outcomes and Measures: A diagnosis of dementia in a hospital inpatient or outpatient contact. Diagnoses of Alzheimer disease and vascular dementia were secondary outcome measures. In primary analyses, distribution of lithium exposure was compared between patients with dementia and controls. Results: A total of 73 731 patients with dementia and 733 653 controls (median age, 80.3 years; interquartile range, 74.9-84.6 years; 44 760 female [60.7%] and 28 971 male [39.3%]) were included in the study. Lithium exposure was statistically significantly different between patients with a diagnosis of dementia (median, 11.5 µg/L; interquartile range, 6.5-14.9 µg/L) and controls (median, 12.2 µg/L; interquartile range, 7.3-16.0 µg/L; P < .001). A nonlinear association was observed. Compared with individuals exposed to 2.0 to 5.0 µg/L, the incidence rate ratio (IRR) of dementia was decreased in those exposed to more than 15.0 µg/L (IRR, 0.83; 95% CI, 0.81-0.85; P < .001) and 10.1 to 15.0 µg/L (IRR, 0.98; 95% CI, 0.96-1.01; P = .17) and increased with 5.1 to 10.0 µg/L (IRR, 1.22; 95% CI, 1.19-1.25; P < .001). Similar patterns were found with Alzheimer disease and vascular dementia as outcomes. Conclusions and Relevance: Long-term increased lithium exposure in drinking water may be associated with a lower incidence of dementia in a nonlinear way; however, confounding from other factors associated with municipality of residence cannot be excluded.

Indexed as

Alzheimer DiseaseDementiaDementia, VascularEnvironmental ExposureAgedAged, 80 and overCase-Control StudiesDenmarkDrinking WaterFemaleHumansIncidenceLithiumMaleStatistics as TopicTimeDrinking WaterLithium

Identifiers

PMID28832877
PMCPMC5710473
OpenAlexW2746935314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.